PUMA BIOTECHNOLOGY, INC. Amortization of Intangible Assets
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Amortization of Intangible Assets of $2.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $2.40M, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $2.40M, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $2.40M, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $2.40M, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for fiscal 2025 was $9.70M, a 0.00% change from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for fiscal 2024 was $9.70M, a 21.25% increase from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for fiscal 2023 was $8.00M, a 0.00% change from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. amortization of intangible assets for fiscal 2022 was $8.00M, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.40M 10-Q · filed 2026-08-06 | $4.90M 10-Q · filed 2026-08-06 | $7.20M derived: sum of 3 quarters · filed 2026-08-06 | $9.60M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $2.40M 10-Q · filed 2026-05-07 | $4.80M derived: sum of 2 quarters · filed 2026-05-07 | $7.20M derived: sum of 3 quarters · filed 2026-05-07 | $9.60M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.80M derived: sum of 2 quarters · filed 2026-02-26 | $7.20M derived: sum of 3 quarters · filed 2026-08-06 | $9.70M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $2.40M 10-Q · filed 2025-11-06 | $4.80M derived: sum of 2 quarters · filed 2026-08-06 | $7.30M 10-Q · filed 2025-11-06 | $9.60M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-06 | $4.90M 10-Q · filed 2026-08-06 | $7.20M derived: sum of 3 quarters · filed 2026-08-06 | $9.60M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $2.40M 10-Q · filed 2026-05-07 | $4.80M derived: sum of 2 quarters · filed 2026-05-07 | $7.20M derived: sum of 3 quarters · filed 2026-05-07 | $9.60M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.80M derived: sum of 2 quarters · filed 2026-02-26 | $7.20M derived: sum of 3 quarters · filed 2026-02-26 | $9.70M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $2.40M 10-Q · filed 2025-11-06 | $4.80M derived: sum of 2 quarters · filed 2025-11-06 | $7.30M 10-Q · filed 2025-11-06 | $7.90M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $2.40M 10-Q · filed 2025-08-07 | $4.90M 10-Q · filed 2025-08-07 | $5.50M derived: sum of 3 quarters · filed 2026-02-26 | $7.90M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $2.40M 10-Q · filed 2025-05-08 | $3.10M derived: sum of 2 quarters · filed 2026-02-26 | $5.50M derived: sum of 3 quarters · filed 2026-02-26 | $7.90M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.10M derived: sum of 2 quarters · filed 2026-02-26 | $5.50M derived: sum of 3 quarters · filed 2026-02-26 | $8.00M 10-K · filed 2026-02-26 | $9.70M 10-K · filed 2024-02-29 | |
| 2023-09-30 | $2.40M 10-Q · filed 2024-11-07 | $4.80M derived: sum of 2 quarters · filed 2024-11-07 | $7.30M 10-Q · filed 2024-11-07 | $9.20M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $2.40M 10-Q · filed 2024-08-01 | $2.50M 10-Q · filed 2023-08-03 | $4.90M 10-Q · filed 2024-08-01 | $6.80M derived: sum of 3 quarters · filed 2025-02-27 | $8.80M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $2.40M 10-Q · filed 2024-05-02 | $4.40M derived: sum of 2 quarters · filed 2025-02-27 | $6.40M derived: sum of 3 quarters · filed 2025-02-27 | $8.40M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.00M derived: sum of 2 quarters · filed 2025-02-27 | $6.00M derived: sum of 3 quarters · filed 2025-02-27 | $8.00M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $2.00M 10-Q · filed 2023-11-02 | $4.00M derived: sum of 2 quarters · filed 2023-11-02 | $6.00M 10-Q · filed 2023-11-02 | $8.00M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $2.00M 10-Q · filed 2023-08-03 | $4.00M 10-Q · filed 2023-08-03 | $6.00M derived: sum of 3 quarters · filed 2024-02-29 | $8.00M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $2.00M 10-Q · filed 2023-05-04 | $4.00M derived: sum of 2 quarters · filed 2024-02-29 | $6.00M derived: sum of 3 quarters · filed 2024-02-29 | $8.00M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $4.00M derived: sum of 2 quarters · filed 2024-02-29 | $6.00M derived: sum of 3 quarters · filed 2024-02-29 | $8.00M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $2.00M 10-Q · filed 2021-11-04 | $4.00M derived: sum of 2 quarters · filed 2021-11-04 | $6.00M 10-Q · filed 2021-11-04 | $8.00M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-06-30 | $2.00M 10-Q · filed 2021-08-05 | $4.00M 10-Q · filed 2021-08-05 | $6.00M derived: sum of 3 quarters · filed 2023-03-02 | $8.00M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-03-31 | $2.00M 10-Q · filed 2021-05-06 | $4.00M derived: sum of 2 quarters · filed 2023-03-02 | $6.00M derived: sum of 3 quarters · filed 2023-03-02 | $7.30M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2020-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $4.00M derived: sum of 2 quarters · filed 2023-03-02 | $5.30M derived: sum of 3 quarters · filed 2023-03-02 | $6.30M 10-K · filed 2023-03-02 | ||
| 2020-09-30 | $2.00M 10-Q · filed 2020-11-05 | $3.30M derived: sum of 2 quarters · filed 2020-11-05 | $4.30M 10-Q · filed 2020-11-05 | $5.20M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-06-30 | $1.30M 10-Q · filed 2020-08-06 | $2.30M 10-Q · filed 2020-08-06 | $3.20M derived: sum of 3 quarters · filed 2022-03-03 | $4.20M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-07 | $1.90M derived: sum of 2 quarters · filed 2022-03-03 | $2.90M derived: sum of 3 quarters · filed 2022-03-03 | $3.90M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2019-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.90M derived: sum of 2 quarters · filed 2022-03-03 | $2.90M derived: sum of 3 quarters · filed 2022-03-03 | $3.90M 10-K · filed 2022-03-03 | ||
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-07 | $2.00M derived: sum of 2 quarters · filed 2019-11-07 | $3.00M 10-Q · filed 2019-11-07 | $3.90M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-09 | $2.00M 10-Q · filed 2019-08-09 | $2.90M derived: sum of 3 quarters · filed 2021-03-01 | $3.90M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $1.00M 10-Q · filed 2020-05-07 | $1.90M derived: sum of 2 quarters · filed 2021-03-01 | $2.90M derived: sum of 3 quarters · filed 2021-03-01 | $3.90M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.90M derived: sum of 2 quarters · filed 2021-03-01 | $2.90M derived: sum of 3 quarters · filed 2021-03-01 | $3.90M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $1.00M 10-Q · filed 2018-11-05 | $2.00M derived: sum of 2 quarters · filed 2018-11-05 | $3.00M 10-Q · filed 2018-11-05 | |||
| 2018-06-30 | $1.00M 10-Q · filed 2018-08-09 | $2.00M 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | $1.00M 10-Q · filed 2018-05-10 | |||||
| 2017-12-31 | $1.60M 10-K · filed 2020-02-28 | |||||
| 2017-09-30 | $600.00K 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |